Search results
Jun 20, 2024 · Michael Shepard, Deloitte's global Financial Crime executive, has retired from Deloitte and is joining the Quantifind advisory board. Quantifind, the proven AI leader in Risk...
H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
Dr. Michael Shepard is an orthopaedic surgeon who specializes in the treatment of knee, elbow and shoulder injuries in Orange and Irvine.
The 2019 Lasker~DeBakey Clinical Medical Research Award honors three scientists—H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich —who invented Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and developed it into a life-saving therapy for women with breast cancer.
Nov 30, 2021 · Dr. Shepard, an innovator in the field of biotechnology and pioneer in cancer research, won the 2019 Lasker-DeBakey Clinical Medical Research Award with colleagues Dr. Dennis J. Slamon and Axel...
Michael Shepard, M.D. is a board certified orthopedist at Hoag Orthopedict Institute, specializing in sports medicine treatment of the elbow, knee, and shoulder.
